The Lancet Microbe 2023

2 papers

Top Research Directions

The 3 research directions with The Lancet Microbe 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Attenuating Pathogen Virulence to Mitigate Selection Pressure1050.0%0.0%—
2Countering the Molecular Mechanisms of Antibiotic Resistance1050.0%0.0%—
3The Challenge of Heterogeneity in Medical Data Synthesis1050.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Lancet Microbe 2023 papers: a paper credits every institution named in its affiliations, once. 9 institutions share 1 credited papers.

#InstitutionPapersShare20222022 rank
1006x48140 1100.0%0—
20080acb59 1100.0%0—
300k27zs44 1100.0%0—
4036ragn25 1100.0%0—
5European Bioinformatics Institute 1100.0%0—
6Stanford University 1100.0%0—
7University of Cambridge 1100.0%11
8University of Oxford 1100.0%0—
9Vita-Salute San Raffaele University 1100.0%0—

Download all institutions as CSV

About this data

Papers. The Lancet Microbe 2023 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 2 to 2 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Microbe 2023”, https://lacuna.tiptreesystems.com/venue/the-lancet-microbe/2023.

Top Authors

AuthorPapers
Elizabeth Stuart1

Papers

Title
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation